Last reviewed · How we verify
Standard medical therapy (SMT)
Standard medical therapy (SMT) is a Small molecule drug developed by Post Graduate Institute of Medical Education and Research, Chandigarh. It is currently in Phase 3 development for Management of various medical conditions.
Standard medical therapy involves the use of established treatments to manage a medical condition.
Standard medical therapy involves the use of established treatments to manage a medical condition. Used for Management of various medical conditions.
At a glance
| Generic name | Standard medical therapy (SMT) |
|---|---|
| Sponsor | Post Graduate Institute of Medical Education and Research, Chandigarh |
| Modality | Small molecule |
| Therapeutic area | General Medicine |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of standard medical therapy can vary depending on the condition being treated, but it often involves the use of medications or other interventions that have been proven to be effective in clinical trials.
Approved indications
- Management of various medical conditions
Common side effects
- Unknown
Key clinical trials
- Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial) (NA)
- Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites (NA)
- Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure. (NA)
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide. (NA)
- A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma (PHASE3)
- Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% (PHASE3)
- Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer (PHASE2)
- Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard medical therapy (SMT) CI brief — competitive landscape report
- Standard medical therapy (SMT) updates RSS · CI watch RSS
- Post Graduate Institute of Medical Education and Research, Chandigarh portfolio CI
Frequently asked questions about Standard medical therapy (SMT)
What is Standard medical therapy (SMT)?
How does Standard medical therapy (SMT) work?
What is Standard medical therapy (SMT) used for?
Who makes Standard medical therapy (SMT)?
What development phase is Standard medical therapy (SMT) in?
What are the side effects of Standard medical therapy (SMT)?
Related
- Manufacturer: Post Graduate Institute of Medical Education and Research, Chandigarh — full pipeline
- Therapeutic area: All drugs in General Medicine
- Indication: Drugs for Management of various medical conditions
- Compare: Standard medical therapy (SMT) vs similar drugs
- Pricing: Standard medical therapy (SMT) cost, discount & access